Talis: COVID-19 test kit maker surges 80% in market debut

Talis Biomedical

12/02/2021 18:43

** Shares of Talis Biomedical Corp  TLIS.O  surged more than
80% to open at $29 in their Nasdaq debut
    ** TLIS had a market cap of $614.2 mln at the opening price 
    ** Co's IPO was priced at $16 per share
    ** It offered 13.8 mln shares in IPO, raising about $220.8
mln
    ** Talis develops molecular diagnostic tests for infectious
diseases
    ** Co submitted an emergency use approval with the US FDA
for its rapid COVID-19 test kit (https://bit.ly/37bfcUp)
    ** J.P. Morgan, BofA Securities and Piper Sandler & Co were
the lead book-running managers for the offering 

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))